Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P39060 (endostatin)
 2,284 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The viability of using microbial transglutaminase (MTGase) as a cold-set binder for restructuring and manufacturing deboned dry ham (RDH) was evaluated. The influence of meat pre-treatment, preparation of the MTGase, packing system and set temperature on the binding rate and force was tested using pork models and deboned legs. The best binding parameters were obtained when meat surfaces were evenly distributed with salts (NaCl, KNO(3), NaNO(2)) and then washed with a saline solution (W), afterwards powder (P) or liquid (L) MTGase was applied, and simultaneous salting and vacuum packing (S) set at 7 degrees C were performed. The RDH manufactured following these procedures (WPS and WLS) was stable during drying and could resist the handling and production process. Binding force increased (p<0.05) during 8 weeks of drying. Scanning electron microscopy analysis showed an increase of cross-links during the drying period of RDH related to the increase in binding force.
 ...
PMID:Microbial transglutaminase for cold-set binding of unsalted/salted pork models and restructured dry ham. 2037 52

The release of an anti-angiogenic agent, such as type XVIII/endostatin, from an implantable scaffold may be of benefit in the repair of articular cartilage. The objectives of this study are to develop an injectable mesenchymal stem cell (MSC)-incorporating collagen-based hydrogel capable of undergoing covalent cross-linking in vivo and overexpressing endostatin using nonviral transfection, and to investigate methods for the retention of the endostatin protein within the scaffolds. The effects of different cross-linking agents (genipin, transglutaminase-2, and microbial transglutaminase) and different binding molecules for endostatin retention (heparin, heparan sulfate, and chondroitin sulfate) are evaluated. Cartilaginous constructs that overexpress endostatin for 3 weeks are successfully engineered. Most of the endostatin is released into the surrounding media and is not retained within the constructs. The presence of two common basement membrane molecules, laminin and type IV collagen, which have been reported in developing and mature articular cartilage and are generally associated with type XVIII collagen in vivo, is also observed in the engineered cartilaginous constructs. Endostatin-producing cartilaginous constructs can be formulated by growing nonvirally transfected mesenchymal stem cells in collagen gels covalently cross-linked using genipin, transglutaminase-2, and microbial transglutaminase. These constructs warrant further investigation for cartilage repair procedures. The novel finding of laminin and type IV collagen in the engineered cartilage constructs may be of importance for future work toward understanding the role of basement membrane molecules in chondrogenesis and in the physiology and pathology of articular cartilage.
 ...
PMID:Engineering endostatin-expressing cartilaginous constructs using injectable biopolymer hydrogels. 2237 Apr 47